Back
iShares LifePath Retirement ETF Vs. Spyre Therapeutics, Inc. Industry Stock Comparison
Sell
15
IRTR
iShares LifePath Retirement ETF
Last Price:
$30.60
Seasonality Move:
2.18%
Buy
63
SYRE
Spyre Therapeutics, Inc.
Last Price:
$47.58
Seasonality Move:
-1.09%
Sell
15
iShares LifePath Retirement ETF (IRTR)
is a Sell
Is iShares LifePath Retirement ETF a Buy, Sell or Hold?
-
The current iShares LifePath Retirement ETF [IRTR] share price is $30.61. The Score for IRTR is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.
-
IRTR is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
63
Spyre Therapeutics, Inc. (SYRE)
is a Buy
Is Spyre Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Spyre Therapeutics, Inc. [SYRE] share price is $47.58. The Score for SYRE is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
-
SYRE is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
IRTR Stock Price Chart
What is iShares LifePath Retirement ETF's stock price today?
-
The iShares LifePath Retirement ETF share price today is $30.61Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IRTR is experiencing buying pressure, which is a positive indicator for future bullish movement.
SYRE Stock Price Chart
What is Spyre Therapeutics, Inc.'s stock price today?
-
The Spyre Therapeutics, Inc. share price today is $47.58The current trend is moderately bullish and SYRE is experiencing slight buying pressure.
IRTR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.19 | Sell |
| Relative Strength Index (14 RSI): | 46.04 | Sell |
| Chaikin Money Flow: | 7168 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (30.41 - 31.21) | Sell |
| Bollinger Bands (100): | (30.65 - 31.33) | Sell |
SYRE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.39 | Buy |
| Relative Strength Index (14 RSI): | 60.73 | Buy |
| Chaikin Money Flow: | 101552 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (40.42 - 46.32) | Buy |
| Bollinger Bands (100): | (28.36 - 41.52) | Buy |
IRTR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 30.45 | Buy |
| 20-day SMA: | 30.66 | Sell |
| 50-day SMA: | 31.1 | Sell |
| 200-day SMA: | 30.58 | Buy |
| 8-day EMA: | 30.52 | Buy |
| 20-day EMA: | 30.68 | Sell |
| 50-day EMA: | 30.91 | Sell |
| 200-day EMA: | 30.5 | Buy |
SYRE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 46.88 | Buy |
| 20-day SMA: | 43.85 | Buy |
| 50-day SMA: | 39.64 | Buy |
| 200-day SMA: | 26.25 | Buy |
| 8-day EMA: | 46.92 | Buy |
| 20-day EMA: | 44.54 | Buy |
| 50-day EMA: | 40.51 | Buy |
| 200-day EMA: | 30.19 | Buy |
iShares LifePath Retirement ETF Earnings Growth & IRTR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Spyre Therapeutics, Inc. Earnings Growth & SYRE Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.51 per share, a decrease this year of $0.72 per share, and a decrease next year of $0.16 per share.
iShares LifePath Retirement ETF Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Spyre Therapeutics, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||